[Clinical guidelines of diagnosis and treatment of gastroesophageal reflux disease].
D000863:Antacids / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004724:Endoscopy; D050782:Esophageal pH Monitoring; D005764:Gastroesophageal Reflux / Q000145:classification / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000628:therapy; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D009853:Omeprazole / Q000008:administration & dosage / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D054328:Proton Pump Inhibitors; D011859:Radiography; D013392:Sucralfate / Q000627:therapeutic use
D000863:Antacids; D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors; D013392:Sucralfate; D009853:Omeprazole